Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...
A multi-disciplinary approach was employed, using a combination of multiomic techniques, including single-cell RNA-sequencing ...
Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...
Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...
Major market opportunities in blood group typing include advancements in PCR and NGS technologies, growing demand for ...
3don MSN
New 'ultra-mild' sequencing method fixes long-standing flaws in cancer DNA methylation tests
Traditional bisulfite sequencing damages DNA, while enzyme-based alternatives are inconsistent. A novel methylation analysis ...
A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform ...
Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most ...
Advances in molecular diagnostics have driven multiplex biomarker detection as a critical approach for enhanced diagnostic ...
2don MSN
GeoVax outlines expedited GEO-MVA clinical trial and global partnership strategy for 2025-2026
Discover key insights from GeoVax Labs’ Q3 2025 earnings call—expedited vaccine trials, partnership updates & clinical progress.
Genetic Testing Market - Test Types, Technologies and Distribution Channels" has been added to ResearchAndMarkets.com's offering. The global DTC genetic testing market is heading for significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results